Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The Phase 1 high-dose trial explored doses up to 16 mg, finding that the compound remained well tolerated even at these higher levels
Increased Energy Expenditure: Activation of the glucagon receptor encourages the body to break down stored fat and increases the metabolic rate, further supporting weight loss
Ozempic and Wegovy are GLP-1 receptor agonists that have been shown to cause significant weight loss and work by reducing appetite and increasing feelings of fullness
Wright EM
Less oversightwhile some compounding pharmacies are excellent, others have less stringent quality control
US$ 27.04
US$ 22.32
US$ 29.12
US$ 29.30
